RxDoctor Payments Data

Kari Bradshaw, NP

Adult Health · Albany, GANPI 1689007049

Payments from drug & device makers

$953in general payments, 2019–2025

Across 50 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$260
  • Novo Nordisk$178
  • AstraZeneca$122
  • Astellas Pharma US Inc$82
  • Hologic Sales And Service, LLC$76
  • Pfizer$49
  • plus $186 from 11 others

What the payments were for

  • Food & beverage$953100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$953 in reported general payments places this provider in the 65th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Medicare billing

Part B allowed, 2024
$8,921
Medicare patients
60
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide20$19,147
TrulicityDulaglutide12$11,390
JardianceEmpagliflozin14$10,481
SynthroidLevothyroxine Sodium14$1,027
Rosuvastatin Calcium59$862
Atorvastatin Calcium40$646
Levothyroxine Sodium46$627
Metoprolol Succinate20$314
Liothyronine Sodium12$301
Lisinopril35$297
Omeprazole13$281
Losartan Potassium30$227
Pantoprazole Sodium12$208
Duloxetine Hcl14$192
Potassium Chloride12$152

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$178$19,14720 claims
Lilly USA, LLCTrulicity$17$11,39012 claims
AbbVieSynthroid$260$1,02714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 577 adult health providers in Georgia.

Other adult health in Albany

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →